Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Flagrante Delictu who wrote (11319)	11/17/1997 12:15:00 PM
From: William B. Kohn	Respond to of 32384

Didn't notice that your back, but I missed you. Welcome back and lets hope we don't have to deal with another suspension of a friend on this thread again.

To: Flagrante Delictu who wrote (11319)	11/17/1997 2:26:00 PM
From: squetch	Read Replies (1) \| Respond to of 32384

Bernie, I am concerned that LGND will pick an expensive dill that will really leave them in a pickle. I am not trying to be a sourpuss, but if they are picking up something that will cost a lot short term to fund, that may leave them over a barrel. I am concerned that SRGN won't contribute much to bottom line at least much in making 99 profitable. I am sure they are looking at any trial data etc. and will make a good decision. Would you care to speculate what the other deal will be?(Henry speculated on an acquisition I think)